Lymphangioleiomyomatosis (Q42952): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Linfangioleiomiomatose (LAM) é uma doença pulmonar de cistos múltiplos, caracterizada por destruição cística progressiva dos pulmões e anormalidades dos linfáticos, frequentemente associada a angiomiolipomas (AML). A LAM ocorre esporadicamente ou como manifestação do complexo da esclerose tuberosa (CET). | |||
| description / en | description / en | ||
Lymphangioleiomyomatosis (LAM) is a multiple cystic lung disease characterised by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas (AMLs). LAM occurs either sporadically or as a manifestation of tuberous sclerosis complex (TSC). | |||
Revision as of 09:43, 13 August 2026
Lymphangioleiomyomatosis (LAM) is a multiple cystic lung disease characterised by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas (AMLs). LAM occurs either sporadically or as a manifestation of tuberous sclerosis complex (TSC).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | CB07 |
||
| English | Lymphangioleiomyomatosis |
Lymphangioleiomyomatosis (LAM) is a multiple cystic lung disease characterised by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas (AMLs). LAM occurs either sporadically or as a manifestation of tuberous sclerosis complex (TSC). |
